Skip to main content
SpringerLink
Log in

How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?

  • Opinions on Therapeutic Aspects
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Evans D.J., Barth J.H., Burke C.W. Body fat topography in women with androgen excess. Int. J. Obes. 12: 157, 1988.

    PubMed  CAS  Google Scholar 

  2. Hauner H., Ditschneit H.H., Pal S.B., Moncayo R., Pfeiffer E.F. Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism. Metabolism. 37: 281, 1988.

    Article  PubMed  CAS  Google Scholar 

  3. Rebuffe-Scrive M., Cullberg G., Lundberg P.A., Lindstedt G., Björntorp P. Anthropometric variables and metabolism in polycystic ovarian disease. Horm. Metab. Res. 21: 391, 1989.

    Article  PubMed  CAS  Google Scholar 

  4. Bringer J., Lefebvre P., Boulet F., Grigorescu F., Renard E., Hedon B., Orsetti A., Jaffiol C. Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles. Ann. N.Y. Acad. Sci. 687: 115, 1993.

    Article  PubMed  CAS  Google Scholar 

  5. Holte J., Bergh T., Gennarelli G., Wide L. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin. Endocrinol. 41: 473, 1994.

    Article  CAS  Google Scholar 

  6. Talbott E., Guzick D., Clerici A., Berga S., Detre K., Weimer K., Kuller L. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler. Thromb. Vasc. Biol. 15: 821, 1995.

    Article  PubMed  CAS  Google Scholar 

  7. Kiddy D.S., Sharp P.S., White D.M., Scanion M.F., Mason H.D., Bray C.S., Poison D.W., Reed M.J., Francks S. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin. Endocrinol. 32: 213, 1990.

    Article  CAS  Google Scholar 

  8. Dale P.O., Tando T., Vaaler S., Abyholm T. Body weight, hyperinsulinemia and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil. Steril. 58: 487, 1992.

    PubMed  CAS  Google Scholar 

  9. Holte J., Torbjörn B., Berne C., Lithell H. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to antropometric, endocrine and metabolic variables. Clin. Endocrinol. 41: 463, 1994.

    Article  CAS  Google Scholar 

  10. Plymate S.R., Fariss B.L., Bassett M.L., Matej L. Obesity and its role in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 52: 1246, 1981.

    Article  PubMed  CAS  Google Scholar 

  11. Graf M.J., Richards C.J., Brown V., Meissner L., Dunaif A. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women. Clin. Endocrinol. 33: 119, 1990.

    Article  CAS  Google Scholar 

  12. Morales A.J., Laughlin G.A., Butzow T., Maheshwari H., Baumann G., Yen S.S.C. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J. Clin. Endocrinol. Metab. 81: 2854, 1996.

    PubMed  CAS  Google Scholar 

  13. Dunaif A., Mandeli J., Fluhr H., Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 66: 131, 1988.

    Article  PubMed  CAS  Google Scholar 

  14. Taylor A.E., McCourt B., Martin K.A., Anderson E.J., Adams J.M., Schonfeld D., Hall J.E. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 82: 2248, 1997.

    PubMed  CAS  Google Scholar 

  15. Pasquali R., Casimirri F., Venturoli S., Antonio M., Morselli L., Reho S., Pezzoli A., Paradisi R. Body fat distribution has weight-independent effects on clinical, hormonal and metabolic features of women with polycystic ovary syndrome. Metabolism. 43: 706, 1994.

    Article  PubMed  CAS  Google Scholar 

  16. Holte J., Torbjörn B., Berne C., Wide L., Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 80: 2586, 1995.

    PubMed  CAS  Google Scholar 

  17. Nestler J.E. Insulin regulation of human androgens. Hum. Reprod. 12(Suppl. 1): 53, 1997.

    Article  PubMed  CAS  Google Scholar 

  18. Nestler J.E., Jacubowicz D.J., De Vargas A.F., Bik C., Quintero N., Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J. Clin. Endocrinol. Metab. 83: 2001, 1998.

    PubMed  CAS  Google Scholar 

  19. Willis D., Mason H., Gilling-Smith C. and Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J. Clin. Endocrinol Metab. 81: 302, 1996.

    PubMed  CAS  Google Scholar 

  20. Dahlgren E., Johanson S., Lindstedt G., Knutsson F., Oden A., Janson P.O., Mattson L.A., Crona N., Lundberg P.A. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil. Steril. 57: 505, 1992.

    PubMed  CAS  Google Scholar 

  21. Dahlgren E., Johanson S., Johansson S., Lapidus L., Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Acta Obstet. Gynecol. Scand. 71: 599, 1992.

    Article  PubMed  CAS  Google Scholar 

  22. Slowinska-Srzednicka J., Zgliczynnski S., Wierzbicky M., Srzednicky M., Stopinska-Gluszak U., Zgliczynnski W., Soszynski P., Chotkowska E., Bednarska M., Sadowski Z. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J. Endocrinol. Invest. 14: 569, 1991.

    Article  PubMed  CAS  Google Scholar 

  23. Conway G.S., Agrawal R., Betteridge D.J., Jacobs H.S. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin. Endocrinol. 37: 119, 1992.

    Article  CAS  Google Scholar 

  24. Guzick D.S., Wing R., Smith D., Berga S.L., Winters S.J. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil. Steril. 61: 598, 1994.

    PubMed  CAS  Google Scholar 

  25. Harlass F.E., Plymate S.R., Fariss B.L., Belts R.P. Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female. Fertil. Steril. 42: 649, 1984.

    PubMed  CAS  Google Scholar 

  26. Crave J.C., Fimbel S., Lejeune H., Cugnardey N., Dechaud H., Pugeat M. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J. Clin. Endocrinol. Metab. 80: 2057, 1995.

    PubMed  CAS  Google Scholar 

  27. Pasquali R., Antenucci D., Casimirri F., Venturoli S., Paradisi R., Fabbri R., Balestra V., Melchionda N., Barbara L. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J. Clin. Endocrinol. Metab. 68: 173, 1989.

    Article  PubMed  CAS  Google Scholar 

  28. Kiddy D.S., Hamilton-Fairley D., Bush A., Short F., Anyaokuy V., Reed M.J., Franks S.D. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. 36: 105, 1992.

    Article  CAS  Google Scholar 

  29. Bates G.W., Whitworth N.S. Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil. Steril. 38: 406, 1982.

    PubMed  CAS  Google Scholar 

  30. Kiddy D.S., Hamilton-Fairley D., Seppala M., Koistinen R., James V.H.T., Reed M.J., Franks S. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I. Clin. Endocrinol. 31: 757, 1989.

    Article  CAS  Google Scholar 

  31. Andersen P., Selfjeflot I., Abdelnoor M., Arnesen H., Dale P.O., Lovik A., Birkeland K. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism, 44: 611, 1995.

    Article  PubMed  CAS  Google Scholar 

  32. Dyer R.G. Traditional treatment of obesity: does it work? In: Caterson I.D. (Eds). Bailliere’s Clinical Endocrinology and metabolism. Obesity 8: 661, 1994.

  33. Wild R.A., Painter P.C., Coulson P.B., Carruth K.B., Ranney G.B. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J. Clin. Endocrinol Metab. 61: 946, 1985.

    Article  PubMed  CAS  Google Scholar 

  34. Apter D., Bützow T., Laughlin G.A., Yen S.S.C. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J. Clin. Endocrinol. Metab. 80: 2966, 1995.

    PubMed  CAS  Google Scholar 

  35. Ibáñez L., Potau N., Zampolli M., Prat N., Virdis R., Vicens-Calvet E., Carrascosa A. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 81: 1237, 1996.

    PubMed  Google Scholar 

  36. Dewailly D., Cortet-Rudelli C., Deroubaix-Allard D. Markers of abdominal adipose tissue in women: relationship to ovarian function. TEM, 9: 68, 1998.

    PubMed  CAS  Google Scholar 

  37. McCluskey S., Evans C., Lacey J.H., Pearce J.M., Jacobs H. Polycystic ovary syndrome and bulimia. Fertil. Steril. 55: 287, 1991.

    PubMed  CAS  Google Scholar 

  38. Dewailly D., Pujol N., Cortet-Rudelli C., Henric B., Fontaine P., Fossati P. Risque cardio-vasculaire et hyperandrogénie ovarienne fonctionnelle. Rev. Franc. Endocrinol. Clin. 35: 299, 1994.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service, d’Endocrinologie et de Diabétologie, Clinique Marc Linquette, U.S.N.A., Centre Hospitalier et Universitaire de Lille, 6 rue du Pr Laguesse, 59037, Lille Cedex, France

    C. Cortet-Rudelli & Didier Dewailly

Authors
  1. C. Cortet-Rudelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Didier Dewailly
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cortet-Rudelli, C., Dewailly, D. How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?. J Endocrinol Invest 21, 636–640 (1998). https://doi.org/10.1007/BF03350791

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350791

Key-words

Search

Navigation